Claim: Jury finding upends Bayer's Roundup defense strategy: experts.
Verdict: SUPPORTS

Retrieved passages:
title: Roundup (herbicide)
text: million in damages after a jury in San Francisco found that Monsanto had failed to adequately warn consumers of cancer risks posed by the herbicide, a decision the company plans on appealing. Johnson had routinely used two different glyphosate formulations in his work as a groundskeeper, RoundUp and another Monsanto product called Ranger Pro. The jury's verdict addressed the question of whether Monsanto knowingly failed to warn consumers that RoundUp could be harmful, but not whether RoundUp causes cancer. Court documents from the case show the company's efforts to influence scientific research via ghostwriting. After the IARC classified glyphosate as

title: Standard Gravure shooting
text: Midway through, defense testimony opened a door that would have allowed plaintiffs to make known to the jury Lilly's 1985 conviction for failing to report to the federal Food and Drug Administration adverse reactions to Oraflex, another Lilly drug. The plaintiffs and Lilly then negotiated an agreement, which they concealed from the trial judge, John W. Potter. The trial continued, and plaintiffs never introduced the precedent of Lilly's conduct with respect to Oraflex. The jury decided in Lilly's favor, and when plaintiffs failed to appeal, a suspecting Judge Potter uncovered the concealed agreement. With unanimous authorization from Kentucky's Supreme Court,

title: Scientific jury selection
text: identify those jurors who would most likely sway the rest of the jury's deliberations, so as to bribe and extort them into pushing for acquittal, but also train one of his henchmen to pose as the perfect "prosecutor's juror" and get placed on the jury. In season one, episode eleven, of the television series "Leverage", a pharmaceutical company is under fire for a wrongful death case involving a stimulative all-natural herbal supplement. In an attempt to prevent major losses for the pharmaceutical company in question, and to protect the investment of a soon-to-be-parent company's subsidiary, scientific jury selection is used.

title: Bayer
text: made to expand the production of its herbicide Liberty. Liberty is an alternative to Monsanto's product, Roundup, which are both used to kill weeds. Bayer CropScience Limited is the Indian subsidiary of Bayer AG. It is listed on the Indian stock exchanges viz. the Bombay Stock Exchange & National Stock Exchange of India and has a market capitalization of $2 billion. Bayer BioScience, headquartered in Hyderabad, India has about 400 employees, and has research, production and an extensive sales network spread across India. Before the 2016 restructuring, Bayer HealthCare comprises a further four subdivisions: Bayer Schering Pharma, Bayer Consumer Care,

title: Robert F. Kennedy Jr.
text: court in San Francisco, on behalf of plaintiffs seeking to recover damages for non-Hodgkins lymphoma, that, the plaintiffs allege, were a result of exposure to Monsanto's glyphosate-based herbicide, Roundup. Kennedy and his team also filed a class action lawsuit against Monsanto for failing to warn consumers about the dangers allegedly posed by exposure to Roundup. In September 2018, Kennedy and his partners filed a class-action lawsuit against Columbia Gas of Massachusetts alleging negligence following gas explosions in three towns north of Boston. Of Columbia Gas, Kennedy said “as they build new miles of pipe, the same company is ignoring its

title: Monsanto legal cases
text: of California filed a motion to dismiss the case. Monsanto appealed on March 22. In 2016, the Southern District of California ruled that Emanuel Giglio's cancer was not Monsanto's fault and that "FIFRA preempted Giglio's claim of a failure to warn the EPA about the dangers of glyphosate". In the "In re: RoundUp Products Liability" multidistrict litigation (MDL) a "Daubert" hearing was held in March 2018 on general causation as to non-Hodgkin’s lymphoma. This case consolidated over 300 federal lawsuits that allege Monsanto did not adequately warn consumers about the risks of using RoundUp. These lawsuits were filed after the

title: Monsanto legal cases
text: Superior Court, against Monsanto alleging damages related to certain forms of cancer caused by Monsanto's Roundup product. On August 10, 2018, Dewayne Johnson won the first jury case against Monsanto based on a causal link between Roundup and Johnson's non-Hodgkin's lymphoma. The jury awarded Johnson $289 million in actual and punitive damages against Monsanto, and found that Monsanto acted maliciously by failing to warn consumers of cancer risks posed by the herbicide. Monsanto plans to appeal the verdict based on its claim that the judge improperly admitted scientific evidence presented on behalf of Johnson. Arkansas and Missouri banned the sale

title: Glyphosate
text: In June 2018, Dewayne Johnson, a 46-year-old former California school groundskeeper who is dying of non-Hodgkin lymphoma, took Monsanto (which had been acquired by Bayer earlier that month) to trial in San Francisco County superior court, alleging that it has spent decades hiding the cancer-causing dangers of its Roundup herbicides. The judge ordered that jurors be allowed to consider both scientific evidence related to the cause of Johnson’s cancer and allegations that Monsanto suppressed evidence of the risks, with possible punitive damages. In August 2018, the jury awarded Johnson US$289 million in damages. Monsanto said they would appeal, saying they

title: Bayer
text: share price dropped by around 14% or $14 Billion. The company filed an appeal on 18 September 2018. It faces 8,700 similar lawsuits alleging Roundup caused cancer. The general consensus among national regulatory agencies, the World Health Organization, and the European Commission is that labeled usage of the herbicide poses no carcinogenic or genotoxic risk to humans. The following is an illustration of the company's major mergers, acquisitions and historical predecessors: In 2003, to separate operational and strategic managements, Bayer AG was reorganized into a holding company. The group's core businesses were transformed into limited companies, each controlled by Bayer

title: Bayer
text: genetically modified rice had contaminated the U.S. rice supply. Shortly after the public learned of the contamination, the E.U. banned imports of U.S. long-grain rice and the futures price plunged. In April 2010, a Lonoke County, Arkansas jury awarded a dozen farmers $48 million. The case is currently on appeal to the Arkansas Supreme Court. On 1 July 2011 Bayer CropScience agreed to a global settlement for up to $750 million. In September 2014, the firm announced plans to invest $1 billion in the United States between 2013 and 2016. A Bayer spokesperson said that the largest investments will be

title: The Litigators
text: must bring experts to testify against Krayoxx and even disreputable experts, the only ones who can be found charge fees in the tens of thousands of dollars. The trial opens as originally scheduled, but the two Finley & Figg partners prove unequal to the task. During opening statements, Oscar suffers a myocardial infarction. Wally attempts to make light of the situation by proclaiming it an example of Krayoxx's side effects. Karros moves for a mistrial and the motion is granted, leading to the need to pick a new jury and the judge imposes a fine on the already financially strained

title: Bayer
text: amount of its current agricultural assets to BASF in a series of deals. On 21 March 2018 the deal was approved by the European Union, and it was approved in the United States on 20 May 2018. The sale closed on 7 June 2018. The Monsanto brand was discontinued; its products will be marketed under the Bayer name. In August 2018, two months after acquiring Monsanto, a U.S. jury ordered Monsanto to pay $289 million to a school groundskeeper who claimed his Non-Hodgkins lymphoma was caused by regularly using Roundup, a glyphosate-based herbicide produced by Monsanto. Following the verdict Bayer's

title: Roundup (herbicide)
text: "probably carcinogenic" in 2015, over 300 federal lawsuits have been filed that were consolidated into a multidistrict litigation called "In re: RoundUp Products Liability". In 1996, Monsanto was accused of false and misleading advertising of glyphosate products, prompting a law suit by the New York State attorney general. Monsanto had made claims that its spray-on glyphosate based herbicides, including Roundup, were safer than table salt and "practically non-toxic" to mammals, birds, and fish, "environmentally friendly", and "biodegradable". Citing avoidance of costly litigation, Monsanto settled the case, admitting no wrongdoing, and agreeing to remove the offending advertising claims in New York

title: Roundup (herbicide)
text: company trademark for its patented line of crop seed that are resistant to Roundup. Between 1990 and 1996 sales of Roundup increased around 20% per year. it is used in over 160 countries. Roundup is used most heavily on corn, soy, and cotton crops that have been genetically modified to withstand the chemical, but since 2012 glyphosate was used in California to treat other crops like almond, peach, cantaloupe, onion, cherry, sweet corn, and citrus. Roundup (herbicide) Roundup is the brand name of a systemic, broad-spectrum glyphosate-based herbicide originally produced by the American company Monsanto, which was acquired by Bayer

title: Monsanto
text: are suing Monsanto in numerous state courts for failure to warn the public about the risk of cancer associated with the glyphosate-based weedkiller Roundup after the IARC report in 2015 linking glyphosate to cancer in humans. Monsanto denies that Roundup is carcinogenic. In March 2017, 40 plaintiffs filed a lawsuit at the Alameda County Superior Court, a branch of the California Superior Court, asking for damages caused by the company’s glyphosate-based weed-killers, including Roundup, and demanding a jury trial. On August 10, 2018, Monsanto lost the first decided case. Dewayne Johnson, who has non-Hodgkin's lymphoma, was initially awarded $289 million

title: Moxifloxacin
text: Bayer, citing the Federal Circuit's prior decision in "Takeda v. Alphapharm" as "affirming the district court's finding that defendant failed to prove a prima facie case of obviousness where the prior art disclosed a broad selection of compounds, any one of which could have been selected as a lead compound for further investigation, and defendant did not prove that the prior art would have led to the selection of the particular compound singled out by defendant." According to Bayer's press release announcing the court's decision, it was noted that Teva had also challenged the validity of the same Bayer patents

title: Project on Scientific Knowledge and Public Policy
text: has issued three rulings which greatly impact the role scientists may play in providing expert testimony. These rulings are "Daubert v. Merrell Dow Pharmaceuticals," "General Electric v. Joiner", and "Kumho Tire Co. v. Carmichael." Each address the "gatekeeper" role of the judge in determining the admissibility of expert testimony, with considerable implications for tort litigation. "Daubert v. Merrell Dow Pharmaceuticals Daubert Standard "Kumho Tire Co. v. Carmichael" Project on Scientific Knowledge and Public Policy The Project on Scientific Knowledge and Public Policy (SKAPP), based at the George Washington University in Washington, D.C., examines the nature of science and the ways

title: International Agency for Research on Cancer
text: criticisms, highlighting that only 17 of 410 of the working-group participants were consultants to industry and these people never served as chairs, nor were allowed to vote. The reason the details of the voting names were not published was to avoid political pressures on the participating Working Group scientists, and to protect the integrity of the deliberative process. On 20 March 2015, IARC classified glyphosate, the most widely used weed killing substance in the world sold under the brand name of "Roundup" by Monsanto, as "probably carcinogenic to humans" (Group 2A). Subsequently, many national regulatory authorities underwent a reevaluation of

title: Daubert v. Merrell Dow Pharmaceuticals, Inc.
text: Daubert v. Merrell Dow Pharmaceuticals, Inc. Daubert v. Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), is a United States Supreme Court case determining the standard for admitting expert testimony in federal courts. The "Daubert" Court held that the enactment of the Federal Rules of Evidence implicitly overturned the Frye standard; the standard that the Court articulated is referred to as the Daubert standard. Jason Daubert and Eric Schuller had been born with serious birth defects. They and their parents sued Merrell Dow Pharmaceuticals Inc., a subsidiary of Dow Chemical Company, in a California District Court, claiming that the drug

title: Avaaz
text: In January 2018, Monsanto requested Avaaz hand over all documents the organization held in relation to glyphosate. Lawyers for the company said they planned to use the documentation in their defense during an upcoming court case involving two plaintiffs in Missouri who say their cancer was caused by exposure to Monsanto's "Roundup" herbicide. Avaaz argued that a successful subpoena would result in a "chilling effect" on the group's work. On September 5, 2018 a New York judge sided with Avaaz. The judge stated that the subpoena "risked "chilling" free speech and political activity", and argued that Monsanto's request was "anti-democratic".